This article was originally published in The Tan Sheet
In the article "Senate Puts FDA On Notice To Solve FDAAA Sec. 912 Puzzle" (1"The Tan Sheet" July 13, 2009), we should not have stated that a citizen petition relating to stevia-based sweeteners in food products "is rendered irrelevant" by FDA's letters of no objection to marketers of stevia products. The letters state FDA's decision does not consider whether the products in question might violate Sec. 912 of FDAAA. "The Tan Sheet" regrets the misstatement
You may also be interested in...
Senate appropriators say FDA must decide how it will implement a provision of the FDA Amendments Act of 2007 that could substantially stifle innovation in the dietary supplement industry
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.
Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients